JP2011105738A5 - - Google Patents

Download PDF

Info

Publication number
JP2011105738A5
JP2011105738A5 JP2011010997A JP2011010997A JP2011105738A5 JP 2011105738 A5 JP2011105738 A5 JP 2011105738A5 JP 2011010997 A JP2011010997 A JP 2011010997A JP 2011010997 A JP2011010997 A JP 2011010997A JP 2011105738 A5 JP2011105738 A5 JP 2011105738A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
pharmaceutically acceptable
acceptable salt
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011010997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011105738A (ja
JP5400812B2 (ja
Filing date
Publication date
Priority claimed from GBGB0412769.2A external-priority patent/GB0412769D0/en
Application filed filed Critical
Publication of JP2011105738A publication Critical patent/JP2011105738A/ja
Publication of JP2011105738A5 publication Critical patent/JP2011105738A5/ja
Application granted granted Critical
Publication of JP5400812B2 publication Critical patent/JP5400812B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011010997A 2004-06-08 2011-01-21 バニロイドアンタゴニストとして有用なキナゾリノン誘導体 Expired - Lifetime JP5400812B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0412769.2A GB0412769D0 (en) 2004-06-08 2004-06-08 Organic compounds
GB0412769.2 2004-06-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007526311A Division JP4703650B2 (ja) 2004-06-08 2005-06-08 バニロイドアンタゴニストとして有用なキナゾリノン誘導体

Publications (3)

Publication Number Publication Date
JP2011105738A JP2011105738A (ja) 2011-06-02
JP2011105738A5 true JP2011105738A5 (cg-RX-API-DMAC10.html) 2012-03-08
JP5400812B2 JP5400812B2 (ja) 2014-01-29

Family

ID=32696854

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007526311A Expired - Lifetime JP4703650B2 (ja) 2004-06-08 2005-06-08 バニロイドアンタゴニストとして有用なキナゾリノン誘導体
JP2011010997A Expired - Lifetime JP5400812B2 (ja) 2004-06-08 2011-01-21 バニロイドアンタゴニストとして有用なキナゾリノン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007526311A Expired - Lifetime JP4703650B2 (ja) 2004-06-08 2005-06-08 バニロイドアンタゴニストとして有用なキナゾリノン誘導体

Country Status (29)

Country Link
US (4) US7960399B2 (cg-RX-API-DMAC10.html)
EP (1) EP1755606B2 (cg-RX-API-DMAC10.html)
JP (2) JP4703650B2 (cg-RX-API-DMAC10.html)
KR (2) KR20100101017A (cg-RX-API-DMAC10.html)
CN (1) CN1956721B (cg-RX-API-DMAC10.html)
AT (1) ATE376833T1 (cg-RX-API-DMAC10.html)
AU (2) AU2005251476C1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0511933B8 (cg-RX-API-DMAC10.html)
CA (1) CA2567821C (cg-RX-API-DMAC10.html)
CY (1) CY1107846T1 (cg-RX-API-DMAC10.html)
DE (1) DE602005003128T3 (cg-RX-API-DMAC10.html)
DK (1) DK1755606T4 (cg-RX-API-DMAC10.html)
EC (2) ECSP067067A (cg-RX-API-DMAC10.html)
ES (1) ES2293584T5 (cg-RX-API-DMAC10.html)
GB (1) GB0412769D0 (cg-RX-API-DMAC10.html)
HR (1) HRP20070577T4 (cg-RX-API-DMAC10.html)
IL (1) IL179532A (cg-RX-API-DMAC10.html)
MA (1) MA28685B1 (cg-RX-API-DMAC10.html)
MX (1) MXPA06014249A (cg-RX-API-DMAC10.html)
NO (1) NO338181B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ551630A (cg-RX-API-DMAC10.html)
PL (1) PL1755606T5 (cg-RX-API-DMAC10.html)
PT (1) PT1755606E (cg-RX-API-DMAC10.html)
RU (2) RU2449995C2 (cg-RX-API-DMAC10.html)
SG (1) SG153811A1 (cg-RX-API-DMAC10.html)
SI (1) SI1755606T2 (cg-RX-API-DMAC10.html)
TN (1) TNSN06405A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005120510A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200609634B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0525068D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
ES2399928T3 (es) 2006-08-23 2013-04-04 Neurogen Corporation Análogos de 2-fenoxipirimidinona
CN101558069A (zh) * 2006-11-06 2009-10-14 神经能质公司 顺式环己基取代的嘧啶酮衍生物
WO2009010529A1 (en) * 2007-07-18 2009-01-22 Novartis Ag Synergistic combinations of vr-1 antagonists and cox-2 inhibitors
US8915362B2 (en) 2008-10-08 2014-12-23 Ultimed, Inc. Sharps container
US8349852B2 (en) * 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
US20120295942A1 (en) 2010-02-01 2012-11-22 Nicholas James Devereux Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (zh) 2010-02-02 2014-12-24 诺华股份有限公司 用作crf受体拮抗剂的环己基酰胺衍生物
US8546416B2 (en) 2011-05-27 2013-10-01 Novartis Ag 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
AU2013255458A1 (en) 2012-05-03 2014-10-09 Novartis Ag L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists
US9776975B2 (en) 2013-03-05 2017-10-03 University Of Notre Dame Du Lac Quinazolinone antibiotics
US10016425B2 (en) 2016-11-03 2018-07-10 King Saud University Anti-ulcerative colitis compound
CR20210215A (es) 2018-10-31 2021-06-17 Gilead Sciences Inc Compuestos de 6-azabencimidazol sustituidos como inhibidores de hpk1
CN117105933A (zh) 2018-10-31 2023-11-24 吉利德科学公司 具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物
CN113453686B (zh) * 2019-02-15 2025-04-15 博士伦爱尔兰有限公司 治疗眼表痛的方法
EP4431497A1 (en) 2019-02-15 2024-09-18 Bausch + Lomb Ireland Limited Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof
JP6994061B2 (ja) 2019-02-15 2022-01-14 ノバルティス アーゲー 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤
US11453681B2 (en) 2019-05-23 2022-09-27 Gilead Sciences, Inc. Substituted eneoxindoles and uses thereof
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе
WO2022029656A1 (en) 2020-08-06 2022-02-10 Novartis Ag Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof
CN116456986A (zh) * 2020-11-17 2023-07-18 苏州晶云药物科技股份有限公司 一种喹唑啉酮衍生物的新晶型及其制备方法
UY39681A (es) 2021-03-26 2022-10-31 Novartis Ag Derivados de ciclobutilo 1,3–sustituidos y sus usos
JP2025531367A (ja) 2022-09-21 2025-09-19 ボシュ + ロム アイルランド リミテッド Trpv1アンタゴニストの結晶多形形態およびその製剤
KR20250030194A (ko) 2023-08-24 2025-03-05 코웨이 주식회사 출수 장치

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US95650A (en) * 1869-10-12 Improvement in machines for bending sheet-metal for cornices
US220227A (en) * 1879-10-07 Improvement in stri klng-movements for clocks
US49728A (en) * 1865-09-05 Improvement
US82365A (en) * 1868-09-22 thompson
DE239090C (cg-RX-API-DMAC10.html) 1906-11-01
US2749344A (en) 1953-01-02 1956-06-05 Burroughs Wellcome Co Pyrimidine compounds
DE1224316B (de) 1961-03-18 1966-09-08 Beiersdorf & Co Ag P Verfahren zur Herstellung von 2-Methyl-3-(o-aethylphenyl)-4-oxo-3, 4-dihydrochinazolin und dessen Salzen
DE1232152B (de) * 1962-06-27 1967-01-12 Heyden Chem Fab Verfahren zur Herstellung von 3-Phenylchinazolinon-(4)-derivaten
US3515787A (en) * 1962-06-27 1970-06-02 Squibb & Sons Inc Compositions and methods for producing a muscle relaxing effect in an animal with 2,3 - substituted - 6 - amino-4-quinazolones
GB1003802A (en) * 1963-06-04 1965-09-08 Searle & Co Pyrimidinone derivatives
DE1280874B (de) * 1963-10-09 1968-10-24 Boehringer Sohn Ingelheim 2-Methyl-3-(2-dimethylaminophenyl)-8-amino-3H-chinazolon-(4)
US3317388A (en) 1964-11-20 1967-05-02 Wallace & Tiernan Inc Methods for treating pain
US3864362A (en) 1970-05-27 1975-02-04 Chinoin Gyogyszer Es Vegyeszet Iso flavones
BE793594A (fr) 1972-01-03 1973-07-02 Pfizer Nouvelles 6,7-dimethoxyquinazolines utiles comme analgesiques et tranquillisants
GB1495305A (en) 1975-09-12 1977-12-14 Pfizer Ltd 3-phenyl-4-oxo-4h-benzopyran derivatives
US4501755A (en) 1981-05-01 1985-02-26 Pennwalt Corporation Isoflavones useful as anti-inflammatory agents
JPS59128376A (ja) * 1983-01-13 1984-07-24 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
SU1262927A1 (ru) 1985-01-09 1997-11-20 Институт физико-органической химии и углехимии АН УССР Способ получения 6-бром-5-метилимидазо(4,5-в)пиридина
JPS62201882A (ja) 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
JPS62193605A (ja) * 1986-02-20 1987-08-25 Toray Ind Inc 半透性複合膜の製造方法
ZA873745B (en) 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
US5290780A (en) * 1991-01-30 1994-03-01 American Cyanamid Co. Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
US5958930A (en) 1991-04-08 1999-09-28 Duquesne University Of The Holy Ghost Pyrrolo pyrimidine and furo pyrimidine derivatives
US5284853A (en) 1993-04-23 1994-02-08 American Cyanamid Company Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5294617A (en) 1993-04-23 1994-03-15 American Cyanamid Company Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
EP0635263A3 (en) 1993-06-28 1995-09-27 American Cyanamid Co Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue.
HUT68558A (en) 1993-07-20 1995-06-28 Chinoin Gyogyszer Es Vegyeszet Method for preparing isoflavon derivatives
IL112235A (en) 1994-01-03 2000-06-29 Acea Pharm Inc 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
JPH07258224A (ja) 1994-03-24 1995-10-09 Dai Ichi Seiyaku Co Ltd 二環性化合物
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
CA2214131C (en) * 1995-03-14 2009-06-23 Novartis Ag Trisubstituted phenyl derivatives
US5783577A (en) 1995-09-15 1998-07-21 Trega Biosciences, Inc. Synthesis of quinazolinone libraries and derivatives thereof
WO1997028118A1 (en) 1996-02-05 1997-08-07 Hoechst Celanese Corporation Process for preparing anthranilic acids
EP0920319A4 (en) 1996-05-20 2002-05-02 Merck & Co Inc GONADOLIBERIN ANTAGONISTS
FR2750862B1 (fr) 1996-07-12 1998-10-16 Dupin Jean Pierre Utilisation d'heterocycles diazotes fusionnes avec un systeme aromatique ou heteroaromatique pour le traitement des maladies thrombo-emboliques
AU6908398A (en) 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
IT1289154B1 (it) 1997-01-03 1998-09-29 Chiesi Farma Spa Derivati di isoflavone loro preparazione e loro impiego terapeutico
JPH10259176A (ja) 1997-03-17 1998-09-29 Japan Tobacco Inc 血管新生阻害作用を有する新規アミド誘導体及びその用途
US5948775A (en) 1997-03-19 1999-09-07 American Home Products Corporation 2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones
DE69819345T2 (de) 1997-08-20 2004-07-15 The Regents Of The University Of California, Oakland Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
AU2466799A (en) 1998-01-22 1999-08-09 Regents Of The University Of California, The Nucleic acid sequences encoding capsaicin receptors
CN1310706A (zh) 1998-02-25 2001-08-29 遗传研究所有限公司 磷脂酶抑制剂
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
DE60024785T2 (de) * 1999-02-22 2006-09-14 Amorepacific Corp. Vanilloid-analoge die resiniferatoxin-pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung
GB9920912D0 (en) 1999-09-03 1999-11-10 Indena Spa Novel derivatives of flavones,xanthones and coumarins
AU4742101A (en) 2000-03-17 2001-10-03 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
JP2004525071A (ja) 2000-07-20 2004-08-19 ニューロジェン コーポレイション カプサイシン受容体リガンド
CA2417507A1 (en) * 2000-08-21 2002-02-28 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
NZ526622A (en) 2000-12-11 2006-07-28 Amgen Sf Llc CXCR3 antagonists
JP4205430B2 (ja) 2001-03-26 2009-01-07 ノバルティス アクチエンゲゼルシャフト 疼痛を治療するための、バニロイド受容体アンタゴニストとして、使用するための縮合ピリジン誘導体
AU2002325381A1 (en) 2001-07-31 2003-02-24 Bayer Healthcare Ag Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
GB0128499D0 (en) 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
IL147416A (en) * 2001-12-31 2008-11-26 Israel State Combined modalities for improved cancer treatment
US7074805B2 (en) * 2002-02-20 2006-07-11 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7381730B2 (en) 2002-03-15 2008-06-03 Bristol-Myers Squibb Company 3-arylquinazoline derivatives as selective estrogen receptor beta modulators
AU2003238157A1 (en) 2002-06-18 2003-12-31 Sankyo Company, Limited Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
CN1665791A (zh) 2002-07-05 2005-09-07 霍夫曼-拉罗奇有限公司 喹唑啉衍生物
EP1398032A1 (en) 2002-09-10 2004-03-17 PheneX Pharmaceuticals AG 4-Oxo-quinazolines as LXR nuclear receptor binding compounds
GB0223730D0 (en) 2002-10-11 2002-11-20 Novartis Ag Organic compounds
US20060052345A1 (en) 2002-11-04 2006-03-09 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
EP1611112B1 (en) 2003-02-11 2012-08-22 Vernalis (Cambridge) Limited Isoxazole compounds as inhibitors of heat shock proteins
US20060089353A1 (en) 2003-03-06 2006-04-27 Maki Iwahashi Indole derivative compounds and drugs containing the compounds as the active ingredient
JP2006193426A (ja) 2003-09-05 2006-07-27 Sankyo Co Ltd 置換された縮環ピリミジン−4(3h)−オン化合物
WO2005040112A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds with pgd2 antagonist activity
AU2004290626A1 (en) 2003-11-14 2005-06-02 Merck Sharp & Dohme Limited Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)
BRPI0507629A (pt) 2004-02-13 2007-07-03 Banyu Pharma Co Ltd composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
GB0412768D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
CA2607929A1 (en) 2005-05-11 2006-11-16 Merck Sharp & Dohme Limited 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2009010529A1 (en) 2007-07-18 2009-01-22 Novartis Ag Synergistic combinations of vr-1 antagonists and cox-2 inhibitors
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists

Similar Documents

Publication Publication Date Title
JP2011105738A5 (cg-RX-API-DMAC10.html)
JP2012111758A5 (cg-RX-API-DMAC10.html)
JP2013532130A5 (cg-RX-API-DMAC10.html)
JP2012107057A5 (cg-RX-API-DMAC10.html)
JP2009149903A5 (cg-RX-API-DMAC10.html)
HRP20192202T1 (hr) Acc inhibitori i njihove upotrebe
JP2011518833A5 (cg-RX-API-DMAC10.html)
JP2013532687A5 (cg-RX-API-DMAC10.html)
JP2011510079A5 (cg-RX-API-DMAC10.html)
JP2011168603A5 (cg-RX-API-DMAC10.html)
JP2013014622A5 (cg-RX-API-DMAC10.html)
JP2015522045A5 (cg-RX-API-DMAC10.html)
JP2013032389A5 (cg-RX-API-DMAC10.html)
JP2013508347A5 (cg-RX-API-DMAC10.html)
JP2012045397A5 (cg-RX-API-DMAC10.html)
JP2012126725A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2014507446A5 (cg-RX-API-DMAC10.html)
ME02558B (me) Inhibitori replikacije virusa gripa
JP2014503607A5 (cg-RX-API-DMAC10.html)
JP2010529196A5 (cg-RX-API-DMAC10.html)
JP2011037885A5 (cg-RX-API-DMAC10.html)
JP2018521020A5 (cg-RX-API-DMAC10.html)
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
JP2011519871A5 (cg-RX-API-DMAC10.html)